| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 11/18/2009 | EP2117595A2 Remotely triggered release from heatable surfaces |
| 11/18/2009 | EP1079875B2 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons |
| 11/18/2009 | CN101583366A Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 11/18/2009 | CN101580506A 1-3 generation arylene ether dendritic phthalocyanine complex and polymer nano-particle thereof |
| 11/17/2009 | US7618627 Monitoring apoptosis in tumor cells by the co-administration of ionizing radiation and an anti-integrin antibody; reducing proliferation of tumor cells |
| 11/12/2009 | WO2009115967A3 Method for the synthesis of hollow spheres |
| 11/12/2009 | WO2009086824A3 Magnetic transducer |
| 11/12/2009 | US20090280061 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 11/11/2009 | EP2116263A1 Reversibly light-switchable drug-conjugates |
| 11/11/2009 | EP2114327A1 Methods and systems of treating age-related macular degeneration |
| 11/11/2009 | CN101575332A Diazacyclo propenyl-contained non-natural nucleoside, preparation method and applications thereof |
| 11/11/2009 | CN100558903C Photochemical internalization for delivery of molecules into the cytosol |
| 11/03/2009 | US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound |
| 10/29/2009 | US20090270317 Pharmaceutical compositions comprising bioelastomer fusion proteins |
| 10/29/2009 | US20090270310 Process for the preparation of a nutrient formulation |
| 10/28/2009 | EP2111232A1 A novel medicinal formulation for inducing an immune response in patients with chronic and recurring infections |
| 10/28/2009 | EP1371640B1 Novel a-lipoic acid derivative and use thereof |
| 10/28/2009 | CN101565421A 1-3 substituted aryloxide dendritic phthalocyanine complexes as well as preparation method and use thereof |
| 10/27/2009 | CA2584638C Medical device for generating transient bubbles |
| 10/27/2009 | CA2369542C Immuno-adjuvant pdt treatment of metastatic tumors |
| 10/22/2009 | DE102008052357A1 Auf ionisierende Strahlung ansprechende Zusammensetzungen, Verfahren und Systeme To ionizing radiation-sensitive compositions, methods and systems |
| 10/20/2009 | CA2245066C Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents |
| 10/15/2009 | WO2009013630A9 Hyperthermia devices and their uses with nanoparticles |
| 10/14/2009 | EP2108378A2 Non-covalent bioconjugates useful for diagnosis and therapy |
| 10/14/2009 | EP2107910A2 Polymer-drug conjugates with tether groups for controlled drug delivery |
| 10/08/2009 | WO2009123575A1 A photosensitising composition and its uses |
| 10/07/2009 | CN101548932A Disposable photophobic photosencitizer storage and release member and production method thereof |
| 10/07/2009 | CN100546648C Transdermal botulinum toxin compositions |
| 10/06/2009 | CA2525980C Sonophoresis skin care device |
| 09/24/2009 | WO2009115967A2 Method for the synthesis of hollow spheres |
| 09/24/2009 | WO2009048532A3 Formation of particles for ultrasound application, drug release, and other uses, and microfluidic methods of preparation |
| 09/24/2009 | WO2009026427A3 Liposome compositions for in vivo administration of boronic acid compounds |
| 09/23/2009 | EP2103313A1 Method for the synthesis of hollow spheres |
| 09/23/2009 | EP1044021B1 Enhanced transport using membrane disruptive agents |
| 09/22/2009 | US7592323 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/17/2009 | WO2008116636A3 Therapeutic plaster for trigger and acupuncture points and for meridian therapy |
| 09/16/2009 | EP2099496A2 Delivery of nanoparticles and/or agents to cells |
| 09/16/2009 | EP2099304A2 Carboranylporphyrins and uses thereof |
| 09/16/2009 | EP1605847B1 Antibody-targeted photodynamic therapy |
| 09/15/2009 | CA2440650C Photosensitizer and method for production thereof |
| 09/09/2009 | EP1578958B1 Method for suppressing immune system response to transplanted tissue or cells |
| 09/09/2009 | CN101524549A New anti-cancer compound |
| 09/09/2009 | CN101524326A Chlorin e6 chitosan-stearic acid graft micelle |
| 09/08/2009 | US7585515 Curable mixture of a bone substitute, a dianhydride of a dicarboxylic acid and an unsaturated carboxylic acid (dimethacrylic anhydride of sebacic acid and/or 1,3-bis(p-carboxyphenoxy)propane), photoinitiator, and redox catalyst; dental, orthopedic and drug delivery applications |
| 09/03/2009 | WO2009107139A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors |
| 09/03/2009 | WO2009047005A3 A homeopathic complex |
| 09/03/2009 | WO2008119556A3 A process to activate extracts derived from living organisms using long wave uv irradiation and compositions comprising said activated extract |
| 09/03/2009 | US20090220454 Use of the histone deacetylase inhibitor N-hydroxy-4-[2-(3-dimethylaminobenzofuran-2-ylcarbonylamino)ethoxy]benzamide (aka CRA-24781, PCI-24781) for treating myelogenous leukemia (MML) or acute myelogenous leukemia (AML), optionally in combination therapy |
| 09/03/2009 | CA2717060A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors |
| 09/02/2009 | EP1773360A4 Acute inflammatory condition treatment |
| 09/02/2009 | EP1472259B1 Tetrapyrrolic macrocycles as photodynamic agents |
| 09/02/2009 | EP1189645B1 Non-covalent bioconjugates useful for diagnosis and therapy |
| 09/02/2009 | EP0995448B1 Compound for diagnosing malignant tumors |
| 09/02/2009 | CN101518545A Synthesis and surface decorating method of rare-earth nanometer compound material |
| 09/01/2009 | US7582287 Method for treating cervical cancer |
| 08/27/2009 | WO2009103816A1 Method for treatment of photosensitivity and phototoxicity |
| 08/27/2009 | CA2716509A1 Method for treatment of photosensitivity and phototoxicity |
| 08/27/2009 | CA2715747A1 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging |
| 08/26/2009 | EP1368057B1 Method to enhance the immunogenicity of an antigen |
| 08/20/2009 | WO2009101344A1 Combination of a light ray with a cytochrome c oxydase substrate particularly for improving the appearance of the skin and/or hair |
| 08/20/2009 | WO2009101143A1 Plasma device for selective treatment of electropored cells |
| 08/20/2009 | US20090209747 Method to inhibit cell growth using oligonucleotides |
| 08/20/2009 | US20090209508 Compounds for Photochemotherapy |
| 08/20/2009 | US20090208483 Antibody selective for dr4 and uses thereof |
| 08/19/2009 | EP2090169A1 Nucleic acid-degrading agent and method for degradation of nucleic acid |
| 08/18/2009 | US7575873 human monoclonal antibody fragment (Fab), cloned by phage display that binds specifically to oxidized forms of low density lipoproteins (OxLDL) and not native LDL; use of the antibody for methods of diagnosis and treatment of atherosclerosis |
| 08/18/2009 | CA2375865C Treatment and analysis of proliferative disorders |
| 08/13/2009 | US20090203757 Ethylene glycol esters as photoactive agents |
| 08/12/2009 | EP1525478B1 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3-expressing tumors |
| 08/12/2009 | EP1503756B1 Epothilone derivative for the treatment of hepatoma and other cancer diseases |
| 08/12/2009 | EP1392328B1 Medicament for protection in radiotherapy |
| 08/12/2009 | CN101502654A Preparation method of high-gloss high-stability Elsinochrome silicon oxide nano granule and application thereof in preparing intravenous injection agent |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2376368C Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor |
| 08/06/2009 | WO2009074811A3 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 08/06/2009 | WO2009067046A3 Method for producing polymer coating on particle surfaces |
| 08/05/2009 | CN101501193A Methods and means for treating DNA repeat instability associated genetic disorders |
| 07/30/2009 | WO2009093144A2 Photodynamic therapy of sebaceous gland disorders |
| 07/30/2009 | WO2009024771A3 Materials and methods for treating cancers which express folate receptors |
| 07/29/2009 | EP2082751A2 Topical formulations in the form of aqueous gels fro the treatment of disorders of the skin and mucous membranes or as vehicules for transdermal administration of natural extractive preparations, substances, molecules and drugs |
| 07/29/2009 | EP1680185A4 Phototherapeutic treatment of skin conditions |
| 07/28/2009 | US7566444 Versatile hydrophilic dyes |
| 07/23/2009 | WO2009091927A1 Ultrasonically active microparticles and method of use |
| 07/23/2009 | US20090186060 Methods of enhancing radiation effects with metal nanoparticles |
| 07/22/2009 | EP2079523A2 Flash photolysis therapy for regulation of physiological function |
| 07/22/2009 | CN101489590A Core-shell nanoparticles for thearapy and imaging purposes |
| 07/21/2009 | US7563819 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 07/21/2009 | CA2406650C Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 07/16/2009 | WO2009088777A1 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 07/16/2009 | US20090181927 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 07/16/2009 | CA2708514A1 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 07/16/2009 | CA2707523A1 Magnetic transducers |
| 07/15/2009 | EP2078528A1 Radiation sensitizer or anti-cancer chemotherapy sensitizer |
| 07/15/2009 | EP2077867A1 Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system |
| 07/15/2009 | EP1750664B1 Intravitreal implants in conjunction with photodynamic therapy to improve vision |
| 07/15/2009 | EP1628681A4 Method of reducing the harmful effects of orally or transdermally delivered nicotine |
| 07/15/2009 | EP1328263B1 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |
| 07/14/2009 | CA2411414C A novel expanded porphyrin and a method for synthesis thereof |
| 07/09/2009 | WO2009084680A1 Gold nanoparticle composition, dna chip, near infrared absorbent, drug carrier for drug delivery system (dds), coloring agent, biosensor, cosmetic, composition for in vivo diagnosis and composition for therapeutic use |
| 07/09/2009 | US20090176279 Bioreactive agents |